Strategic Research Program 17 (VUB Funding)

计划入组 18 人 · 首次发布于 2018 年 4 月 17 日

Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients

计划入组 55 人 · 首次发布于 2019 年 4 月 23 日

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

计划入组 250 人 · 首次发布于 2024 年 10 月 24 日

VUF-11264

VIB-153

VUFB-17649

Vrije Universiteit Brussel

Belgium

HUB

AUB Group Ltd

Cellular Map of Healthy Pancreas Reveals Origins of Aggressive Tumors, Challenging One-Size-Fits-All Treatment

Spica Therapeutics Secures €1 Million VLAIO Grant to Advance Anti-CD163 Monoclonal Antibody for Cancer Treatment

Almirall Advances Etherna's Intratumoral mRNA Therapy LAD116 to Clinical Development for Non-Melanoma Skin Cancer